SELL Dr. Reddy's Laboratories Limited — Deven Choksey, DRChoksey
byDeven Choksey, DRChokseyHorizon: NA (inferred 1 year)29 Oct 2025via Institutional / Brokerage Research
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this SELL call — facts from public sources, machine-classified. Not investment advice.
Dr. Reddy's Laboratories shares fall 7% as most analysts remain bearish after Q1 earnings miss
NewsCnbc-Tv18·23 Jul · today
Dr. Reddy's Laboratories shares will react to weak Q1 after US-listed ADR falls 10%
NewsCnbc-Tv18·23 Jul · today
Dr. Reddy's Laboratories shares will react to weak Q1 after US-listed ADR falls 10%
NewsCnbc-Tv18·23 Jul · today
Dr Reddy's Q1 Results: Semaglutide API provision weighs on profit; margin halves
NewsCnbc-Tv18·22 Jul · today
4 advisors have active short-term SELL calls on this stock, with 3 issued in the last 14 days
Advisor consensus · adjacent horizon·23 Jul · today
Dr. Reddy's Laboratories Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.
NSE · Outcome of Board Meeting·22 Jul · today
Dr. Reddy's Laboratories will release its Q1FY27 financial results on Wednesday, July 22nd, 2026. An earnings call is scheduled for the same day to discuss financial performance.
NSE · Press Release·13 Jul · 1w ago
Dr. Reddy's Laboratories will announce its Q1FY27 financial results on Wednesday, July 22nd, 2026, followed by an earnings call at 19:30 PM IST.
BSE · Company Update·13 Jul · 1w ago
3 other SEBI-registered advisors have active long-term BUY calls on this stock, with 1 issued in the last 14 days
Advisor consensus · same horizon·23 Jul · today
1 advisor has an active short-term BUY call on this stock, issued in the last 14 days
Advisor consensus · adjacent horizon·10 Jul · 2w ago
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Dr. Reddy's Laboratories
- BUY — Aditya Agarwal, Coheron Brokers22 Oct 2026 · ~2 weeks · target ₹1,340 · Active
- BUY — Osho Krishan, Angel One22 Oct 2026 · ~2 weeks · target ₹1,290 · Active
- BUY — Swati Hotkar, Nirmal Bang Securities21 Oct 2026 · ~2 weeks · target ₹1,290 · SL hit
- BUY — Prakash Gaba21 Oct 2026 · Same day · target ₹1,260 · Expired
- BUY — Rajesh Satpute19 Oct 2026 · Next day · target ₹1,280 · Expired
More from Deven Choksey, DRChoksey
- BUY ICICI Bank21 Oct 2026 · ~1 year · target ₹1,847 · Active
- BUY HDFC Bank21 Oct 2026 · ~1 year · target ₹981 · Active
- BUY Axis Bank21 Oct 2026 · ~1 year · target ₹1,507 · Active
- BUY Bajaj Housing Finance21 Oct 2026 · ~1 year · target ₹110 · Active
- SELL Tata Technologies16 Oct 2026 · ~1 year · target ₹700 · Target hit

